PROSPECTUS SUPPLEMENT NO. 1                     Filed pursuant to Rule 424(b)(3)
(To Prospectus dated September 12, 2002)             Registration No. 333-98947


                            [IntegraMed America Logo]

                                  Common Stock

This Prospectus Supplement No. 1 supplements and amends the Prospectus dated
September 12, 2002 relating to the 325,600 shares of common stock, including
105,600 shares to be issued upon the exercise of warrants, to be sold at various
times at market prices prevailing at the time of sale or at privately negotiated

The table on page 19 of the prospectus, which set forth information with respect
to the selling stockholders and the respective amount of shares of common stock
beneficially owned by each selling stockholder is hereby amended as follows:

   The deletion from the prospectus of:

   H. C. Wainwright & Co., Inc.             6,160(11)     6,160      -        *
   Julia Aryeh                              8,800(11)     8,800      -        *

   and the substitution of the following:

   Julia Aryeh                              14,960(11)    14,960     -        *
   (11)  Consists  of shares  of  common  stock  underlying  warrants  currently
         exercisable at an exercise price of $6.25 per share.

The prospectus, together with this Prospectus Supplement No. 1, constitutes the
prospectus required to be delivered by Section 5(b) of the Securities Act of
1933, as amended, with respect to offers and sales of the notes and the common
stock issuable upon conversion of the notes. All reference in the prospectus to
"this prospectus" are hereby amended to read "this prospectus (as supplemented
and amended)"

Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a
criminal offense.

            The date of this Prospectus Supplement is June 17, 2003.